title: Metabolic risk factors among medicaid outpatients with schizophrenia receiving second-generation antipsychotics.
abstract: OBJECTIVE
  Schizophrenia is associated with significant reductions in life expectancy, largely because of the increased incidence of cardiovascular disease. This study examined the prevalence of metabolic risk factors for cardiovascular disease among Medicaid recipients diagnosed as having schizophrenia and taking second-generation antipsychotics (medications associated with increased risk of metabolic abnormalities contributing to cardiovascular disease).
  
  
  METHODS
  Fifteen community health centers in King County, Washington, identified 1,317 eligible individuals, of whom 819 completed screenings for obesity, impaired fasting glucose levels or diabetes, hypertension, and dyslipidemia.
  
  
  RESULTS
  Fasting serum levels were obtained for 675 individuals, of whom 90% were diagnosed as having at least one risk factor, with elevated body mass index and dyslipidemia the most prevalent factors. About one-third of the individuals approached to participate did not obtain laboratory work necessary for the screening.
  
  
  CONCLUSIONS
  The study indicates that this population has a high rate of metabolic risk of cardiovascular disease and that treatment will require addressing barriers to screening.
authors: Rochester Psychiatric Center, 1111 Elmwood Ave., Rochester, NY 14620, USA. romdrcb@omh.state.ny.us
authors: Ryan C
authors: RC
authors: Bell
authors: Sharon
authors: S
authors: Farmer
authors: Richard
authors: R
authors: Ries
authors: Debra
authors: D
authors: Srebnik
mesh_terms: D000328:Adult; D000553:Ambulatory Care; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015992:Body Mass Index; D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000453:epidemiology*; D003430:Cross-Sectional Studies; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced / Q000453:epidemiology; D005260:Female; D006306:Health Surveys; D006801:Humans; D006937:Hypercholesterolemia / Q000139:chemically induced / Q000453:epidemiology; D006973:Hypertension / Q000139:chemically induced / Q000453:epidemiology; D008297:Male; D008403:Mass Screening / Q000706:statistics & numerical data; D008484:Medicaid / Q000706:statistics & numerical data*; D008875:Middle Aged; D012307:Risk Factors; D012559:Schizophrenia / Q000188:drug therapy* / Q000453:epidemiology; D014481:United States; D014861:Washington
chemical_list: D014150:Antipsychotic Agents